| Literature DB >> 21914176 |
Christophe Faisy1, Francisco M Pinto, Morgan Le Guen, Emmanuel Naline, Stanislas Grassin Delyle, Edouard Sage, Maria-Luz Candenas, Philippe Devillier.
Abstract
INTRODUCTION: Lung inflation may have deleterious effects on the alveoli during mechanical ventilation. However, the consequences of stretch during excessive lung inflation on basal tone and responsiveness of human bronchi are unknown. This study was undertaken to devise an experimental model of acute mechanical stretch in isolated human bronchi and to investigate its effect on airway tone and responsiveness.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21914176 PMCID: PMC3334752 DOI: 10.1186/cc10443
Source DB: PubMed Journal: Crit Care ISSN: 1364-8535 Impact factor: 9.097
Figure 1Effect of mechanical stress on airway tone and responsiveness. (a) Basal tone and responsiveness to acetylcholine (ACh) in single control and stretched human bronchial rings. After tissue equilibration in an organ bath for 60 minutes, acute mechanical stretch (5 minutes, 2.5 × basal tone) provokes a quick rise of basal tone (immediate contraction corresponding to post-stretch peak) followed by a prolonged plateau (sustained contraction). (b) Post-stretch peak is strain-dependent with a maximal response for a tension corresponding to 2.5-fold resting basal tone in 11 human bronchial rings. (c) Responsiveness to ACh is not significantly altered by stretching in the same 11 paired bronchial rings. Filled squares, stretch 2 × basal tone; filled triangles, stretch 2.5 × basal tone; filled circles, stretch 3 × basal tone; open squares, paired controls. Values are means ± standard error of the mean. *P < 0.001 vs. paired control.
Effects of pretreatment on the rise of airway basal tone (g) in human bronchi at peak or plateau post-stretch (5 minutes, 2
| Post-stretch peak | Post-stretch plateau | ||||
|---|---|---|---|---|---|
| Pretreatment | n | Control | Pretreated | Control | Pretreated |
| Epithelium removal | 12 | 1.43 ± 0.21 | 0.93 ± 0.15 | 1.38 ± 0.22 | 0.89 ± 0.16 |
| MK476 (0.1 μM) | 13 | 1.47 ± 0.19 | 0.89 ± 0.18 | 1.45 ± 0.19 | 0.61 ± 0.18 |
| Indomethacin (1 μM) | 9 | 1.25 ± 0.23 | 1.29 ± 0.23 | 1.21 ± 0.24 | 1.21 ± 0.21 |
| 1400 W (1 mM) | 11 | 1.19 ± 0.11 | 0.89 ± 0.14 | 1.13 ± 0.11 | 0.79 ± 0.16 |
| L-NAME (1 μM) | 9 | 1.16 ± 0.12 | 0.97 ± 0.29 | 1.09 ± 0.11 | 0.91 ± 0.29 |
| L-NAME (1 mM) | 13 | 1.37 ± 0.20 | 0.86 ± 0.16 | 1.31 ± 0.22 | 0.80 ± 0.16 |
| Nω-propyl-L-arginine (5 mM) | 11 | 1.19 ± 0.11 | 0.83 ± 0.09 | 1.13 ± 0.11 | 0.84 ± 0.10 |
| SR 140333 + SR 48968 + | 9 | 1.01 ± 0.12 | 0.90 ± 0.16 | 0.96 ± 0.12 | 0.92 ± 0.17 |
| BQ 123 + BQ 788 (0.1 μM each) | 6 | 1.08 ± 0.16 | 1.20 ± 0.17 | 1.01 ± 0.14 | 1.17 ± 0.24 |
| Atropine (0.1 μM) | 9 | 1.23 ± 0.20 | 1.02 ± 0.22 | 1.16 ± 0.20 | 1.05 ± 0.22 |
| Gadolinium (0.1 mM) | 7 | 1.12 ± 0.11 | 0.98 ± 0.14 | 1.05 ± 0.12 | 0.95 ± 0.15 |
| Mepyramine (1 μM) | 9 | 1.15 ± 0.24 | 1.33 ± 0.20 | 1.11 ± 0.24 | 1.24 ± 0.23 |
| Y27632 (1 μM) | 7 | 1.12 ± 0.11 | 0.15 ± 0.07 | 1.05 ± 0.12 | 0.11 ± 0.05 |
Values are means ± standard error of the mean. < 0.05; < 0.01; < 0.001 vs. paired control. 1400 W, selective inhibitor of inducible nitric oxide synthase; BQ 123, selective endothelin ETA-receptor antagonist; BQ 788, selective endothelin ETB-receptor antagonist; L-NAME, L-nitroarginine methyl ester; MK476, leukotriene Cyst-LT1 receptor antagonist; SR 140333, tachykinin NK1-receptor antagonist; SR 48968, tachykinin NK2-receptor antagonist; SR 142801, tachykinin NK3-receptor antagonist; Y27632, selective Rho-kinase (ROCK1 and ROCK2) inhibitor.
Effects of pretreatments on airway responsiveness in human bronchi post-stretch (5 minutes, 2
| Δ(-log EC50) ACh (log unit) | ΔEmax ACh (g) | ||||
|---|---|---|---|---|---|
| Pretreatment | n | Control | Pretreated | Control | Pretreated |
| Epithelium removal | 12 | 0.31 ± 0.12 | -0.02 ± 0.14 | 0.28 ± 0.23 | -0.06 ± 0.19 |
| MK476 (0.1 μM) | 13 | 0.12 ± 0.22 | 0.10 ± 0.24 | 1.03 ± 0.57 | -0.30 ± 0.44 |
| Indomethacin (1 μM) | 9 | 0.08 ± 0.30 | 0.77 ± 0.39 | 0.74 ± 0.86 | 1.29 ± 0.59 |
| 1400 W (1 mM) | 11 | 0.02 ± 0.18 | -0.20 ± 0.28 | 0.22 ± 0.33 | -0.02 ± 0.26 |
| L-NAME (1 μM) | 9 | 0.16 ± 0.17 | 0.24 ± 0.11 | 0.45 ± 0.24 | -0.04 ± 0.25 |
| L-NAME (1 mM) | 13 | 0.15 ± 0.25 | -0.08 ± 0.13 | 0.11 ± 0.21 | -0.16 ± 0.22 |
| Nω-propyl-L-arginine (5 mM) | 11 | 0.02 ± 0.18 | 0.34 ± 0.20 | 0.22 ± 0.33 | 0.14 ± 0.61 |
| SR 140333 + SR 48968 + | 9 | 0.30 ± 0.16 | 0.11 ± 0.17 | 0.02 ± 0.09 | 0.14 ± 0.42 |
| BQ 123 + BQ 788 (0.1 μM each) | 6 | 0.17 ± 0.19 | 0.72 ± 0.20 | -0.35 ± 0.22 | 1.12 ± 0.32 |
| Gadolinium (0.1 mM) | 7 | 0.24 ± 0.17 | 0.47 ± 0.15 | -0.16 ± 0.27 | 1.34 ± 0.42 |
| Mepyramine (1 μM) | 9 | -0.03 ± 0.36 | -0.09 ± 0.24 | 1.45 ± 0.81 | 0.58 ± 0.46 |
| Y27632 (1 μM) | 7 | 0.24 ± 0.17 | -0.02 ± 0.10 | -0.16 ± 0.27 | 0.05 ± 0.31 |
Values are means ± standard error of the mean. P < 0.01; < 0.001 vs. paired control. 1400 W, selective inhibitor of inducible nitric oxide synthase; Ach, acetylcholine; BQ 123, selective endothelin ETA-receptor antagonist; BQ 788, selective endothelin ETB-receptor antagonist; L-NAME, L-nitroarginine methyl ester; MK476, leukotriene Cyst-LT1 receptor antagonist; SR 140333, tachykinin NK1-receptor antagonist; SR 48968, tachykinin NK2-receptor antagonist; SR 142801, tachykinin NK3-receptor antagonist; Y27632, selective Rho-kinase (ROCK1 and ROCK2) inhibitor.
Figure 2ELISA analysis of organ-bath fluid. Effect of stretch (5 minutes, 2.5 × basal tone) on the production of leukotriene E4 (LTE4), prostaglandin screening (PG), and prostaglandin E2 (PGE2) in an organ bath assessed by ELISA during the immediate contraction following stretch (Figure 1) in 14 human bronchi (controls, open bars). Stretch (filled bars) induced a higher stable excretory LTE4 production. Values are means ± standard error of the mean. *P < 0.05 vs. paired control.
ΔmRNA for the housekeeping genes (ACTB, B2M, GAPDH, HPRT1, and RPL13A) in human bronchi after suspension in an organ bath with (5 minutes, 2
| No stretch | Stretch | |||
|---|---|---|---|---|
|
| Paired rings | ΔmRNA | Paired rings | ΔmRNA |
| 9 | 0.11 ± 0.58 | 9 | 0.01 ± 0.62 | |
| 9 | -0.40 ± 0.46 | 9 | -0.40 ± 0.45 | |
| 9 | 1.18 ± 0.42 | 9 | -0.88 ± 0.39 | |
| 9 | 0.14 ± 0.59 | 9 | -0.31 ± 0.61 | |
| 9 | -0.07 ± 0.52 | 9 | 0.47 ± 0.50 | |
After normalization to the mean of the five housekeeping genes, ΔmRNA for each target gene was calculated as the fold mRNA-value change of each non-stretched or stretched ring relative to the mRNA value in its paired control H0. Values are mean ± standard error of the mean. No significant differences in expression of house-keeping genes were observed. ACTB, β-actin; B2M, β2-microglobulin; GAPDH, glyceraldhyde-3-phosphate dehydrogenase; HPRT1, hypoxantine phosphoribosyltransferase 1; RPL13A, ribosomal protein L13α.
Figure 3RT-PCR array. Effect of stretch (5 minutes, 2.5 × basal tone) on the early mRNA expression (3 hours after stretching) of genes implicated in (a) cell inflammation, (b) cell migration-adhesion, (c) cell growth-differentiation, (d) cell apoptosis, and (e) Wnt-mediated signal transduction. mRNA expression represents the ratio of experimental value/H0 value (fold difference). Filled bars, stretch; open bars, paired controls. Values are means ± standard error of the mean (n = 9). *P < 0.01; P < 0.001 vs. paired control.